What is Artificial Labs?
Artificial Labs operates at the intersection of insurance and enterprise software, providing a sophisticated platform designed to streamline the placement and underwriting of specialty risks. By connecting disparate market participants and automating complex, manual workflows, the company enables teams to prioritize high-value risk assessments and foster stronger client relationships. Its technology stack is engineered to elevate data quality, effectively addressing the legacy inefficiencies that have historically plagued the specialty coverage market. As the industry shifts toward digital-first operations, Artificial Labs serves as a foundational layer for firms seeking to improve operational agility and underwriting precision.
How much funding has Artificial Labs raised?
Artificial Labs has raised a total of $55.3M across 3 funding rounds:
Angel/Seed
$5.3M
Series A
$5.1M
Series B
$45M
Angel/Seed (2019): $5.3M with participation from Force Over Mass
Series A (2024): $5.1M led by Ms&ad Ventures, Augmentum Fintech, and Force Over Mass
Series B (2026): $45M supported by CommerzVentures, Force Over Mass Capital, Augmentum Fintech, Move Capital, 6 Degrees Capital, and TrueSight Ventures
Key Investors in Artificial Labs
CommerzVentures
An independent venture capital firm backed by Commerzbank, specializing in early-stage FinTech and InsurTech investments across Europe, Israel, and the USA.
Force Over Mass Capital
A venture capital firm focused on backing contrarian founders and early-stage businesses, providing strategic support and innovative financial structures to facilitate growth.
Augmentum Fintech
The UK's only publicly listed investment company dedicated to the fintech sector, providing patient capital to high-growth businesses disrupting traditional financial services.
What's next for Artificial Labs?
With this major enterprise-level funding, Artificial Labs is well-positioned to accelerate its product roadmap and expand its footprint across international insurance hubs. The strategic focus will likely center on deepening the platform's AI-driven analytics capabilities and scaling its integration ecosystem to support larger, more complex enterprise clients. By leveraging the expertise of its institutional backers, the company is poised to transition from a specialized solution provider to a dominant force in the digital transformation of the global specialty insurance market, ensuring long-term scalability and sustained competitive advantage.
See full Artificial Labs company page
